Skip to content
HowShorted

Sientra, Inc. short interest in 2023

In 2023, Sientra, Inc.'s disclosed short interest ran from 11.46% of shares outstanding on 13 Jan 2023 to 11.39% on 29 Dec 2023, a change of -0.07 percentage points. The year's high was 19.62% on 15 Jun 2023 and its low 11.19% on 15 Dec 2023, averaging 14.75% across 19 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 41.84 days on 13 Oct 2023. Full history: Sientra, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023

Aggregate net short position time series for Sientra, Inc. in 2023

2023 in figures

Start of year
11.46% (13 Jan 2023)
End of year
11.39% (29 Dec 2023)
Change
-0.07 pp
High
19.62% (15 Jun 2023)
Low
11.19% (15 Dec 2023)
Average
14.75%
Highest days to cover
41.84 (13 Oct 2023)
SEC filings marked
9

Every report in 2023

Sientra, Inc. short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 202311.46%27.27
14 Apr 202315.41%15.63results (8-K)
28 Apr 202314.19%6.8110-K filed
15 May 202313.96%23.89results (8-K), 10-Q filed
31 May 202314.19%2.96
15 Jun 202319.62%1.00
30 Jun 202316.61%1.87
14 Jul 202316.71%2.33
31 Jul 202315.58%5.24
15 Aug 202316.45%7.72results (8-K), 10-Q filed
31 Aug 202315.84%27.89
15 Sep 202315.66%18.88
29 Sep 202316.06%12.73
13 Oct 202315.54%41.84
31 Oct 202314.54%7.10results (8-K)
15 Nov 202313.84%4.56results (8-K), 10-Q filed
30 Nov 202312.07%11.70
15 Dec 202311.19%9.58
29 Dec 202311.39%11.58

See also: Sientra, Inc.'s full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.